ZA984967B - Crystal modification of a pharmaceutical agent - Google Patents

Crystal modification of a pharmaceutical agent

Info

Publication number
ZA984967B
ZA984967B ZA984967A ZA984967A ZA984967B ZA 984967 B ZA984967 B ZA 984967B ZA 984967 A ZA984967 A ZA 984967A ZA 984967 A ZA984967 A ZA 984967A ZA 984967 B ZA984967 B ZA 984967B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical agent
crystal modification
crystal
modification
pharmaceutical
Prior art date
Application number
ZA984967A
Other languages
English (en)
Inventor
Robert Portmann
Urs Christoph Hofmeier
Andreas Burkhard
Walter Scherrer
Martin Szelagiewicz
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=4209650&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA984967(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of ZA984967B publication Critical patent/ZA984967B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA984967A 1997-06-10 1998-06-09 Crystal modification of a pharmaceutical agent ZA984967B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH140497 1997-06-10

Publications (1)

Publication Number Publication Date
ZA984967B true ZA984967B (en) 1999-01-11

Family

ID=4209650

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA984967A ZA984967B (en) 1997-06-10 1998-06-09 Crystal modification of a pharmaceutical agent
ZA984966A ZA984966B (en) 1997-06-10 1998-06-09 Crystal modification of a pharmaceutical agent

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA984966A ZA984966B (en) 1997-06-10 1998-06-09 Crystal modification of a pharmaceutical agent

Country Status (37)

Country Link
US (6) US6740669B1 (es)
EP (2) EP0994863B1 (es)
JP (2) JP3672574B2 (es)
KR (2) KR100425656B1 (es)
CN (3) CN1298708C (es)
AR (4) AR012946A1 (es)
AT (2) ATE232852T1 (es)
AU (2) AU725528B2 (es)
BR (2) BR9804947A (es)
CA (3) CA2256013C (es)
CO (2) CO4940448A1 (es)
CY (1) CY2007014I1 (es)
CZ (2) CZ292481B6 (es)
DE (3) DE122007000051I2 (es)
DK (2) DK0994863T3 (es)
ES (2) ES2192779T3 (es)
FR (1) FR07C0037I2 (es)
HK (3) HK1028242A1 (es)
HU (2) HU225153B1 (es)
ID (2) ID27660A (es)
IL (2) IL125732A (es)
LU (1) LU91345I2 (es)
MY (2) MY120156A (es)
NL (1) NL300284I2 (es)
NO (2) NO329314B1 (es)
NZ (2) NZ331370A (es)
PE (2) PE79799A1 (es)
PL (2) PL192114B1 (es)
PT (1) PT994864E (es)
RU (2) RU2198167C2 (es)
SI (2) SI0994864T1 (es)
SK (2) SK283734B6 (es)
TR (2) TR199801631T1 (es)
TW (2) TW526195B (es)
UY (1) UY25844A1 (es)
WO (2) WO1998056772A1 (es)
ZA (2) ZA984967B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW526195B (en) 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
DE60319980T2 (de) * 2002-05-31 2009-04-16 Schering Corporation Xanthin-phosphodiesterase-v-hemmer polymorphe
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7875284B2 (en) * 2006-03-10 2011-01-25 Cook Incorporated Methods of manufacturing and modifying taxane coatings for implantable medical devices
US20090069390A1 (en) * 2007-09-12 2009-03-12 Protia, Llc Deuterium-enriched rufinamide
CA2736703A1 (en) 2008-10-13 2010-04-22 Cipla Limited Process for the preparation of rufinamide
CN101768124B (zh) * 2008-12-30 2012-01-04 北京本草天源药物研究院 一种药物晶体及其制备方法和用途
IT1395736B1 (it) * 2009-08-04 2012-10-19 Dipharma Francis Srl Forme cristalline di rufinamide
CN104817507A (zh) * 2009-09-04 2015-08-05 巧妙疗法股份有限公司 用于制备5-氨基或取代的氨基1,2,3-三唑和三唑乳清酸盐制剂的新组合物和方法
EP2465853A1 (en) * 2010-12-14 2012-06-20 Laboratorios Lesvi, S.L. Polymorph of rufinamide and process for obtaining it
JP2013525413A (ja) * 2010-04-30 2013-06-20 ラボラトリオス レスヴィ，エス．エル． ルフィナマイド中間体の改良された製造方法
ITMI20110718A1 (it) 2011-04-29 2012-10-30 Dipharma Francis Srl Procedimento per la purificazione di rufinamide
US10206874B2 (en) 2012-07-20 2019-02-19 Hetero Research Foundation Rufinamide solid dispersion
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992378A (en) 1973-12-26 1976-11-16 Eli Lilly And Company Fluoralkyl quinoxadinediones
US4156734A (en) * 1976-02-13 1979-05-29 Merck & Co., Inc. Antihypertensive compositions containing an aryl-substituted alanine azo and an arylhydrazino-propionic acid
GB1511195A (en) 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4346097A (en) * 1980-09-30 1982-08-24 Warner-Lambert Company Method for treating convulsions with pyrazole-4-carboxamide derivatives
FI834666A (fi) 1982-12-23 1984-06-24 Ciba Geigy Ag Foerfarande foer framstaellning av nya aralkyltriazolfoereningar.
US4789680A (en) * 1982-12-23 1988-12-06 Ciba-Geigy Corporation Aralkyltriazole compounds
US4511572A (en) * 1983-03-18 1985-04-16 The University Of Kentucky Research Foundation Triazoline anticonvulsant drugs
PH22568A (en) 1985-04-18 1988-10-17 Ciba Geigy Ag Fluorinated benzyl triazoles and pharmaceutical compositions containing the same
CA2002864C (en) 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
JPH02214504A (ja) 1989-02-15 1990-08-27 Nissan Chem Ind Ltd 光学活性キノキサリン化合物の晶析法
EP0484437A4 (en) 1989-07-27 1994-06-01 Searle & Co Renal-selective prodrugs for the treatment of hypertension
IL96507A0 (en) 1989-12-08 1991-08-16 Merck & Co Inc Nitrogen-containing spirocycles and pharmaceutical compositions containing them
US5283244A (en) 1990-11-06 1994-02-01 Yamanouchi Pharmaceutical Co., Ltd. Fused pyrazine derivatives
JP2753911B2 (ja) 1991-12-06 1998-05-20 キッセイ薬品工業株式会社 Ｎ−ｔｅｒｔ−ブチル−１−メチル−３，３−ジフェニルプロピルアミン塩酸塩の結晶多形およびその製造方法
DE4217952A1 (de) 1992-05-30 1993-12-02 Basf Ag Chinoxalin-2,3(1H,4H)-dione
US5248699A (en) * 1992-08-13 1993-09-28 Pfizer Inc. Sertraline polymorph
US5631373A (en) 1993-11-05 1997-05-20 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
GB9418443D0 (en) 1994-09-13 1994-11-02 Pfizer Ltd Therapeutic agents
GB9419318D0 (en) 1994-09-24 1994-11-09 Pfizer Ltd Therapeutic agents
DK0812320T3 (da) 1995-02-22 2003-04-14 Aventis Pharma Ltd Amorft piretanid, polymorfe former deraf, fremgangsmåde til fremstilling deraf og deres anvendelse
SK283990B6 (sk) * 1996-07-11 2004-07-07 Novartis Ag Spôsob prípravy 1-substituovaných 4-kyano-1,2,3-triazolov, 4-kyano-1-(2,6-difluórbenzyl)-1H-1,2,3-triazol
TW526195B (en) * 1997-06-10 2003-04-01 Novartis Ag Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use

Also Published As

Publication number Publication date
CA2256015A1 (en) 1998-12-17
SK109498A3 (en) 1998-12-02
TR199801631T1 (xx) 1999-06-21
LU91345I2 (fr) 2007-09-04
HU225153B1 (en) 2006-07-28
WO1998056772A1 (en) 1998-12-17
ES2197485T3 (es) 2004-01-01
EP0994863A1 (en) 2000-04-26
KR100409168B1 (ko) 2004-01-31
PL330798A1 (en) 1999-06-07
DK0994863T3 (da) 2003-05-26
DE122007000051I2 (de) 2009-02-19
DE122007000051I1 (de) 2007-11-08
CZ292260B6 (cs) 2003-08-13
CZ253498A3 (cs) 1999-04-14
IL125732A (en) 2002-12-01
ZA984966B (en) 1999-01-11
MY125854A (en) 2006-08-30
SK283734B6 (sk) 2003-12-02
WO1998056773A1 (en) 1998-12-17
NO983666L (no) 1998-12-17
HUP0000798A2 (hu) 2000-10-30
CN1217716A (zh) 1999-05-26
CA2614926C (en) 2010-02-09
US20010037029A1 (en) 2001-11-01
HK1028242A1 (en) 2001-02-09
HU226107B1 (en) 2008-04-28
TW403740B (en) 2000-09-01
CZ292481B6 (cs) 2003-09-17
CA2256013C (en) 2007-10-16
IL125733A (en) 2002-12-01
AR061005A2 (es) 2008-07-30
US20060116520A1 (en) 2006-06-01
US6740669B1 (en) 2004-05-25
TR199801630T1 (xx) 1999-06-21
NL300284I1 (nl) 2007-10-01
NO983667D0 (no) 1998-08-11
CN1298708C (zh) 2007-02-07
KR19990087835A (ko) 1999-12-27
IL125733A0 (en) 1999-04-11
ATE232852T1 (de) 2003-03-15
US6455556B2 (en) 2002-09-24
HK1028241A1 (en) 2001-02-09
NO329315B1 (no) 2010-09-27
KR100425656B1 (ko) 2004-05-17
HUP0002113A2 (hu) 2001-02-28
AR012945A1 (es) 2000-11-22
JP2000516258A (ja) 2000-12-05
KR19990087836A (ko) 1999-12-27
CA2614926A1 (en) 1998-12-17
RU2194041C2 (ru) 2002-12-10
IL125732A0 (en) 1999-04-11
ES2192779T3 (es) 2003-10-16
CZ253398A3 (cs) 1999-04-14
US20100310655A1 (en) 2010-12-09
BR9804946A (pt) 1999-08-24
ID27660A (id) 2001-04-19
SI0994864T1 (en) 2003-10-31
DE69813560D1 (de) 2003-05-22
AR061004A2 (es) 2008-07-30
DE69813560T2 (de) 2004-02-05
CN1572789A (zh) 2005-02-02
HK1028031A1 (en) 2001-02-02
LU91345I9 (es) 2018-12-31
SK283685B6 (sk) 2003-12-02
CN1132820C (zh) 2003-12-31
TW526195B (en) 2003-04-01
FR07C0037I1 (es) 2007-08-17
AU8437198A (en) 1998-12-30
CY2007014I2 (el) 2009-11-04
AU725528B2 (en) 2000-10-12
EP0994864A1 (en) 2000-04-26
PL330764A1 (en) 1999-05-24
CO4940452A1 (es) 2000-07-24
PT994864E (pt) 2003-07-31
EP0994863B1 (en) 2003-02-19
EP0994864B1 (en) 2003-04-16
US20040167186A1 (en) 2004-08-26
JP3672574B2 (ja) 2005-07-20
SI0994863T1 (en) 2003-08-31
SK109398A3 (en) 1998-12-02
NZ331370A (en) 2000-08-25
ATE237599T1 (de) 2003-05-15
NO983667L (no) 1998-12-17
MY120156A (en) 2005-09-30
CN1259127A (zh) 2000-07-05
DE69811500D1 (de) 2003-03-27
PL191943B1 (pl) 2006-07-31
PE79799A1 (es) 1999-09-03
HUP0000798A3 (en) 2000-10-30
DE69811500T2 (de) 2004-04-01
AU725517B2 (en) 2000-10-12
US8076362B2 (en) 2011-12-13
PE80999A1 (es) 1999-09-06
US20030125568A1 (en) 2003-07-03
RU2198167C2 (ru) 2003-02-10
ID21014A (id) 1999-04-08
FR07C0037I2 (es) 2008-05-16
CN1159300C (zh) 2004-07-28
NL300284I2 (nl) 2007-11-01
NO329314B1 (no) 2010-09-27
NZ331371A (en) 2000-08-25
NO983666D0 (no) 1998-08-11
CY2007014I1 (el) 2009-11-04
CO4940448A1 (es) 2000-07-24
AU8437298A (en) 1998-12-30
JP3672575B2 (ja) 2005-07-20
DK0994864T3 (da) 2003-07-21
HUP0002113A3 (en) 2002-09-30
UY25844A1 (es) 2001-08-27
BR9804947A (pt) 1999-08-24
CA2256015C (en) 2008-06-03
PL192114B1 (pl) 2006-08-31
JP2000516259A (ja) 2000-12-05
CA2256013A1 (en) 1998-12-17
US7750028B2 (en) 2010-07-06
AR012946A1 (es) 2000-11-22

Similar Documents

Publication Publication Date Title
HUP0002209A3 (en) 4-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives and pharmaceutical compositions containing them
IL133906A0 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
ZA985618B (en) Sulfonamide compounds and pharmaceutical use thereof
PL305701A1 (en) Pharmaceutical agent
GB9700504D0 (en) Pharmaceutical compounds
SG76535A1 (en) Pharmaceutical agents
GB9726563D0 (en) Novel pharmaceutical
EP0941039A4 (en) TRANSDERMAL ADMINISTRATION OF 7alpha-METHYL-19-NORTESTOSTERONE ("MENT")
ZA984967B (en) Crystal modification of a pharmaceutical agent
GB9726566D0 (en) Novel pharmaceutical
EP1003495A4 (en) PHARMACEUTICAL COMPOUNDS
EG23694A (en) Novel pharmaceutical
GB9716244D0 (en) Pharmaceutical compounds
ZA98300B (en) Pharmaceutical compounds
IL130209A (en) Therapeutic application of a thienylcylohexylamine derivatives
GB9809444D0 (en) Use of a sugar
IL123788A0 (en) (+)-O-demethyltramadol for use as a pain-killing drug for oral application
ZA9810718B (en) Novel crystal modification of thiazine-indigo
GB9706376D0 (en) Novel pharmaceutical
AU5343498A (en) Thiophene compounds and medicinal use thereof
TW328219U (en) Structure of a chair-ladder
HU9700442D0 (en) Compounds of pharmaceutical activity
SI0998473T1 (en) Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use
PL307197A1 (en) Pharmaceutical agent
GB9722873D0 (en) A pharmaceutical